The Department of Health – Abu Dhabi (DoH), the Abu Dhabi Investment Office (ADIO), and GSK, a global leader in biopharmaceuticals, have joined forces to establish a Multi-Omics Research Institute in Abu Dhabi. This partnership was formalized with a Memorandum of Understanding (MoU) signed during the Abu Dhabi Global Health Week (ADGHW). The initiative aims...
